Reuters logo
BRIEF-Bavarian Nordic starts Phase 2 clinical trial of RSV vaccine
October 18, 2016 / 1:27 PM / a year ago

BRIEF-Bavarian Nordic starts Phase 2 clinical trial of RSV vaccine

Oct 18 (Reuters) - Bavarian Nordic A/S :

* Starts Phase 2 clinical trial of RSV vaccine

* Top-line results from study are anticipated around mid-2017

* Top-line results are expected to provide important information for subsequent Phase 2b field efficacy study, which is planned for initiation later in 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below